Analyze Diet
Journal of clinical microbiology1998; 36(2); 506-512; doi: 10.1128/JCM.36.2.506-512.1998

Association of deficiency in antibody response to vaccine and heterogeneity of Ehrlichia risticii strains with Potomac horse fever vaccine failure in horses.

Abstract: Ehrlichia risticii is the causative agent of Potomac horse fever (PHF), which continues to be an important disease of horses. Commercial inactivated whole-cell vaccines are regularly used for immunization of horses against the disease. However, PHF is occurring in large numbers of horses in spite of vaccination. In a limited study, 43 confirmed cases of PHF occurred between the 1994 and 1996 seasons; of these, 38 (89%) were in horses that had been vaccinated for the respective season, thereby clearly indicating vaccine failure. A field study of horses vaccinated with two PHF vaccines indicated a poor antibody response, as determined by immunofluorescence assay (IFA) titers. In a majority of horses, the final antibody titer ranged between 40 and 1,280, in spite of repeated vaccinations. None of the vaccinated horses developed in vitro neutralizing antibody in their sera. Similarly, one horse experimentally vaccinated three times with one of the vaccines showed a poor antibody response, with final IFA titers between 80 and 160. The horse did not develop in vitro neutralizing antibody or antibody against the 50/85-kDa strain-specific antigen (SSA), which is the protective antigen of the original strain, 25-D, and the variant strain of our laboratory, strain 90-12. Upon challenge infection with the 90-12 strain, the horse showed clinical signs of the disease. The horse developed neutralizing antibody and antibody to the 50/85-kDa SSA following the infection. Studies of the new E. risticii isolates from the field cases indicated that they were heterogeneous among themselves and showed differences from the 25-D and 90-12 strains as determined by IFA reactivity pattern, DNA amplification finger printing profile, and in vitro neutralization activity. Most importantly, the molecular sizes of the SSA of these isolates varied, ranging from 48 to 85 kDa. These studies suggest that the deficiency in the antibody response to the PHF vaccines and the heterogeneity of E. risticii isolates may be associated with the vaccine failure.
Publication Date: 1998-02-18 PubMed ID: 9466767PubMed Central: PMC104568DOI: 10.1128/JCM.36.2.506-512.1998Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article examines the ineffectiveness of vaccines used in combating Potomac horse fever (PHF) in horses due to the deficiency in antibody response to the vaccines and the inconsistencies of the Ehrlichia risticii (causative pathogen) strains.

Research Overview

  • The research was instigated by the observation that a large number of horses were contracting PHF even though they had been vaccinated against the disease. To quantify this, a study was conducted between 1994 and 1996, where it was found that 89% of the confirmed PHF cases were in horses that had been vaccinated for the respective season.
  • The study was then extended to the horses vaccinated with two types of PHF vaccines, where it was found that these vaccines induced a poor antibody response as was determined by immunofluorescence assay (IFA) titers.
  • An experimental horse was given vaccinations three times, but it showed a poor antibody response and did not develop neutralizing antibodies. When the horse was infected with a strain of E. risticii, it presented PHF clinical signs, further demonstrating the vaccine’s failure.

Vaccine Failure and Antibody Response

  • The study discovered that none of the vaccinated horses developed in vitro neutralizing antibody in their sera – this suggests that the vaccines were failing to stimulate an effective immune response.
  • There was an observed poor antibody response – the final antibody titer ranged from 40 to 1,280, despite repeated vaccinations.
  • The experimentally vaccinated horse also showed a deficient antibody response and did not develop any neutralizing antibody. However, this horse developed the neutralizing antibody after being infected with the E. risticii strain, indicating that the disease triggered the appropriate antibody response.

Heterogeneity of Ehrlichia risticii Strains

  • New E. risticii isolates from the field cases were found to be variable and different from the original strain used for the vaccines.
  • The differences were seen in the IFA reactivity pattern, DNA amplification fingerprinting profile, and in vitro neutralization activity.
  • Interestingly, the molecular sizes of the strain-specific antigen (SSA) of these isolates varied, ranging from 48 to 85 kDa. The SSAs are the protective antigens.

Conclusion

  • The research concludes that the deficiency in antibody response and the diversity of the E. risticii strains may be associated with the observed vaccine failure. This suggests a need to adapt the vaccines to be more effective against the disease.

Cite This Article

APA
Dutta SK, Vemulapalli R, Biswas B. (1998). Association of deficiency in antibody response to vaccine and heterogeneity of Ehrlichia risticii strains with Potomac horse fever vaccine failure in horses. J Clin Microbiol, 36(2), 506-512. https://doi.org/10.1128/JCM.36.2.506-512.1998

Publication

ISSN: 0095-1137
NlmUniqueID: 7505564
Country: United States
Language: English
Volume: 36
Issue: 2
Pages: 506-512

Researcher Affiliations

Dutta, S K
  • Virginia-Maryland Regional College of Veterinary Medicine, University of Maryland, College Park 20742, USA.
Vemulapalli, R
    Biswas, B

      MeSH Terms

      • Animals
      • Antibodies, Bacterial / biosynthesis
      • Antibodies, Bacterial / immunology
      • Antigens, Bacterial / immunology
      • Blotting, Western
      • DNA, Bacterial / analysis
      • DNA, Bacterial / genetics
      • Ehrlichia / genetics
      • Ehrlichia / immunology
      • Ehrlichia / isolation & purification
      • Ehrlichiosis / immunology
      • Ehrlichiosis / prevention & control
      • Ehrlichiosis / veterinary
      • Fluorescent Antibody Technique
      • Horses
      • Neutralization Tests
      • Polymerase Chain Reaction
      • Rickettsial Vaccines / immunology
      • Treatment Failure
      • Vaccination
      • Vaccines, Inactivated / immunology

      References

      This article includes 32 references
      1. Biswas B, Mukherjee D, Mattingly-Napier BL, Dutta SK. Diagnostic application of polymerase chain reaction for detection of Ehrlichia risticii in equine monocytic ehrlichiosis (Potomac horse fever).. J Clin Microbiol 1991 Oct;29(10):2228-33.
      2. Biswas B, Vemulapalli R, Dutta SK. Detection of Ehrlichia risticii from feces of infected horses by immunomagnetic separation and PCR.. J Clin Microbiol 1994 Sep;32(9):2147-51.
      3. Biswas B. Molecular basis of antigenic variation of strain-specific surface antigen gene of Ehrlichia risticii and development of a multiplex PCR assay for differentiation of strains. Ph.D. Dissertation. College Park: University of Maryland; 1996.
      4. Chaichanasiriwithaya W, Rikihisa Y, Yamamoto S, Reed S, Crawford TB, Perryman LE, Palmer GH. Antigenic, morphologic, and molecular characterization of new Ehrlichia risticii isolates.. J Clin Microbiol 1994 Dec;32(12):3026-33.
      5. Dawson JE, Ristic M, Holland CJ, Whitlock RH, Sessions J. Isolation of Ehrlichia risticii, the causative agent of Potomac horse fever, from the fetus of an experimentally infected mare.. Vet Rec 1987 Sep 5;121(10):232.
        pubmed: 3672833doi: 10.1136/vr.121.10.232google scholar: lookup
      6. Dutta SK, Myrup AC, Rice RM, Robl MG, Hammond RC. Experimental reproduction of Potomac horse fever in horses with a newly isolated Ehrlichia organism.. J Clin Microbiol 1985 Aug;22(2):265-9.
        pmc: PMC268372pubmed: 4031040doi: 10.1128/jcm.22.2.265-269.1985google scholar: lookup
      7. Dutta SK, Penney BE, Myrup AC, Robl MG, Rice RM. Disease features in horses with induced equine monocytic ehrlichiosis (Potomac horse fever).. Am J Vet Res 1988 Oct;49(10):1747-51.
        pubmed: 3189992
      8. Dutta SK, Mattingly BL, Shankarappa B. Antibody response to Ehrlichia risticii and antibody reactivity to the component antigens in horses with induced Potomac horse fever.. Infect Immun 1989 Oct;57(10):2959-62.
      9. Dutta SK, Shankarappa B, Thaker SR, Mattingly-Napier BL. DNA restriction endonuclease cleavage pattern and protein antigen profile of Ehrlichia risticii.. Vet Microbiol 1990 Oct;25(1):29-38.
        pubmed: 2247934doi: 10.1016/0378-1135(90)90090-igoogle scholar: lookup
      10. Dutta S K, Shakarappa B, Mattingly-Napier B L. Antigenic analysis of Ehrlichia risticii isolates. Equine infectious Diseases VI Cambridge, England: R&W Publication Ltd.; 1991. pp. 61–65.
      11. Hahn NE, Perry BD, Rice RM, Hansen JW, Turner EC. Role of blackflies in the epidemiology of Potomac horse fever.. Vet Rec 1989 Sep 2;125(10):273-4.
        pubmed: 2800259doi: 10.1136/vr.125.10.273google scholar: lookup
      12. Holland CJ, Ristic M, Cole AI, Johnson P, Baker G, Goetz T. Isolation, experimental transmission, and characterization of causative agent of Potomac horse fever.. Science 1985 Feb 1;227(4686):522-4.
        pubmed: 3880925doi: 10.1126/science.3880925google scholar: lookup
      13. Holland C J, Weiss E, Burgdorfer W, Cole A I, Kakoma I. Ehrlichia risticii sp. nov.: etiological agent of equine monocytic ehrlichiosis (synonym, Potomac horse fever). Int J Syst Bacteriol 1985;35:524–526.
      14. Kahler S. Transmission is unsolved mystery of equine monocytic ehrlichiosis.. J Am Vet Med Assoc 1989 Jun 15;194(12):1681-5, 1687.
        pubmed: 2753790
      15. Kaylor PS, Crawford TB, McElwain TF, Palmer GH. Passive transfer of antibody to Ehrlichia risticii protects mice from ehrlichiosis.. Infect Immun 1991 Jun;59(6):2058-62.
      16. Levine JF, Levy MG, Nicholson WL, Irby WS, Gager R, Apperson CS. Attempted mechanical transfer of Ehrlichia risticii by tabanids (Diptera: Tabanidae).. J Med Entomol 1992 Sep;29(5):806-12.
        pubmed: 1404259doi: 10.1093/jmedent/29.5.806google scholar: lookup
      17. Long MT, Goetz TE, Whiteley HE, Kakoma I, Lock TE. Identification of Ehrlichia risticii as the causative agent of two equine abortions following natural maternal infection.. J Vet Diagn Invest 1995 Apr;7(2):201-5.
        pubmed: 7619902doi: 10.1177/104063879500700206google scholar: lookup
      18. Madigan JE, Rikihisa Y, Palmer JE, DeRock E, Mott J. Evidence for a high rate of false-positive results with the indirect fluorescent antibody test for Ehrlichia risticii antibody in horses.. J Am Vet Med Assoc 1995 Dec 1;207(11):1448-53.
        pubmed: 7493874
      19. Messick JB, Rikihisa Y. Inhibition of binding, entry, or intracellular proliferation of Ehrlichia risticii in P388D1 cells by anti-E. risticii serum, immunoglobulin G, or Fab fragment.. Infect Immun 1994 Aug;62(8):3156-61.
      20. Palmer JE. Prevention of Potomac horse fever.. Cornell Vet 1989 Jul;79(3):201-5.
        pubmed: 2666021
      21. Palmer JE, Benson CE, Whitlock RH. Resistance to development of equine ehrlichial colitis in experimentally inoculated horses and ponies.. Am J Vet Res 1990 May;51(5):763-5.
        pubmed: 2337274
      22. Rhabach B W, Breider M A, Gerhardt R R, Henton J E. The characteristic, treatment, and control of equine monocytic ehrlichiosis. Vet Med 1993;88:448–451.
      23. Rikihisa Y, Perry BD. Causative ehrlichial organisms in Potomac horse fever.. Infect Immun 1985 Sep;49(3):513-7.
        pmc: PMC261191pubmed: 4030092doi: 10.1128/iai.49.3.513-517.1985google scholar: lookup
      24. Rikihisa Y, Jiang BM. Effect of antibiotics on clinical, pathologic and immunologic responses in murine Potomac horse fever: protective effects of doxycycline.. Vet Microbiol 1989 Mar;19(3):253-62.
        pubmed: 2497577doi: 10.1016/0378-1135(89)90071-0google scholar: lookup
      25. Rikihisa Y, Wada R, Reed SM, Yamamoto S. Development of neutralizing antibody in horses infected with Ehrlichia risticii.. Vet Microbiol 1993 Jul;36(1-2):139-47.
        pubmed: 8236775doi: 10.1016/0378-1135(93)90135-tgoogle scholar: lookup
      26. Schmidtmann ET, Robl MG, Carroll JF. Attempted transmission of Ehrlichia risticii by field-captured Dermacentor variabilis (Acari: Ixodidae).. Am J Vet Res 1986 Nov;47(11):2393-5.
        pubmed: 3789501
      27. van der Kolk JH, Bernadina WE, Visser IJ. [A horse seropositive for Ehrlichia risticii].. Tijdschr Diergeneeskd 1991 Jan 15;116(2):69-72.
        pubmed: 1996460
      28. Vemulapalli R, Biswas B, Dutta SK. Pathogenic, immunologic, and molecular differences between two Ehrlichia risticii strains.. J Clin Microbiol 1995 Nov;33(11):2987-93.
      29. Vemulapalli R, Biswas B, Dutta SK. Studies with recombinant proteins of Ehrlichia risticii: identification of strain-specific antigen as a protective antigen.. Vet Parasitol 1998 Apr 15;76(3):189-202.
        pubmed: 9615953doi: 10.1016/s0304-4017(97)00209-4google scholar: lookup
      30. Vidor E, Bissul G, Moreau Y, Madec J L, Cador J L. Serologie positive a Ehrlichia risticii chez une jument presentant un tableau d’ehrlichiose equine. Pratique Vet Equine 1988;20:5–10.
      31. Wen B, Rikihisa Y, Fuerst PA, Chaichanasiriwithaya W. Diversity of 16S rRNA genes of new Ehrlichia strains isolated from horses with clinical signs of Potomac horse fever.. Int J Syst Bacteriol 1995 Apr;45(2):315-8.
        pubmed: 7537065doi: 10.1099/00207713-45-2-315google scholar: lookup
      32. Whitlock R J, Palmer J E, Meinersman R J, Crane S A. Evaluation of an experimental vaccine for Potomac horse fever. Proceedings of the Symposium on Potomac Horse Fever, 1987 1987; pp. 61–62.

      Citations

      This article has been cited 10 times.
      1. Teymournejad O, Lin M, Bekebrede H, Kamr A, Toribio RE, Arroyo LG, Baird JD, Rikihisa Y. Isolation and Molecular Analysis of a Novel Neorickettsia Species That Causes Potomac Horse Fever. mBio 2020 Feb 25;11(1).
        doi: 10.1128/mBio.03429-19pubmed: 32098825google scholar: lookup
      2. McKenzie HC, Funk RA, Trager L, Werre SR, Crisman M. Immunogenicity of Potomac horse fever vaccine when simultaneously co-administered with rabies vaccine in a multivalent vaccine or as two monovalent vaccines at separate sites. Equine Vet J 2019 Nov;51(6):774-778.
        doi: 10.1111/evj.13096pubmed: 30859618google scholar: lookup
      3. Shaw SD, Stämpfli H. Diagnosis and Treatment of Undifferentiated and Infectious Acute Diarrhea in the Adult Horse. Vet Clin North Am Equine Pract 2018 Apr;34(1):39-53.
        doi: 10.1016/j.cveq.2017.11.002pubmed: 29426709google scholar: lookup
      4. Lin M, Bachman K, Cheng Z, Daugherty SC, Nagaraj S, Sengamalay N, Ott S, Godinez A, Tallon LJ, Sadzewicz L, Fraser C, Dunning Hotopp JC, Rikihisa Y. Analysis of complete genome sequence and major surface antigens of Neorickettsia helminthoeca, causative agent of salmon poisoning disease. Microb Biotechnol 2017 Jul;10(4):933-957.
        doi: 10.1111/1751-7915.12731pubmed: 28585301google scholar: lookup
      5. Xiong Q, Bekebrede H, Sharma P, Arroyo LG, Baird JD, Rikihisa Y. An Ecotype of Neorickettsia risticii Causing Potomac Horse Fever in Canada. Appl Environ Microbiol 2016 Oct 1;82(19):6030-6.
        doi: 10.1128/AEM.01366-16pubmed: 27474720google scholar: lookup
      6. Gibson KE, Pastenkos G, Moesta S, Rikihisa Y. Neorickettsia risticii surface-exposed proteins: proteomics identification, recognition by naturally-infected horses, and strain variations. Vet Res 2011 Jun 2;42(1):71.
        doi: 10.1186/1297-9716-42-71pubmed: 21635728google scholar: lookup
      7. Lin M, Zhang C, Gibson K, Rikihisa Y. Analysis of complete genome sequence of Neorickettsia risticii: causative agent of Potomac horse fever. Nucleic Acids Res 2009 Oct;37(18):6076-91.
        doi: 10.1093/nar/gkp642pubmed: 19661282google scholar: lookup
      8. Rikihisa Y, Zhang C, Kanter M, Cheng Z, Ohashi N, Fukuda T. Analysis of p51, groESL, and the major antigen P51 in various species of Neorickettsia, an obligatory intracellular bacterium that infects trematodes and mammals. J Clin Microbiol 2004 Aug;42(8):3823-6.
      9. Kanter M, Mott J, Ohashi N, Fried B, Reed S, Lin YC, Rikihisa Y. Analysis of 16S rRNA and 51-kilodalton antigen gene and transmission in mice of Ehrlichia risticii in virgulate trematodes from Elimia livescens snails in Ohio. J Clin Microbiol 2000 Sep;38(9):3349-58.
      10. Biswas B, Vemulapalli R, Dutta SK. Molecular basis for antigenic variation of a protective strain-specific antigen of Ehrlichia risticii. Infect Immun 1998 Aug;66(8):3682-8.